Considered to be the model for quality, compassionate care for people facing a serious or life-limiting illness or injury, hospice care involves a team-oriented approach to expert medical care, pain management, and emotional and spiritual support expressly tailored to the patient’s needs and wishes. Patients with life-ending and shortening diseases suffer symptoms of chronic pain, nausea, and anorexia. Evidence continues to evolve regarding the role of medical cannabis to treat these symptoms and improving the quality of life for hospice and palliative care patients. .

Unfortunately, patients and their caregivers are receiving little information or support from healthcare providers regarding the increasingly widespread use of medical cannabis or, cannabinoid-based medicines (CBM) for symptom relief. Providers are perplexed by the lack of available evidence-based research on CBM and the increased interest patients and their families have in CBM. 

CannabizMD Founder/CEO Jacquie Cohen Roth, MS hosted the webinar “Hospice + Palliative Care: Medical Cannabis Complement or Alternative” with three hospice and palliative care healthcare providers: Nurse Toni, Dr. Jaclyn Schneider, M.D., and Dr. Blake Pearson. Despite diversity in their respective clinical practice and geographic location, they share a commitment to the therapeutic benefits of medical cannabis for their patients. The ensuing conversation goes beyond hospice and palliative care to treating veterans and community members’ PTSD with medical cannabis; medical cannabis in the Canadian healthcare system; dosing standards; the challenges of polypharmacy, and how to overcome the stigma held by provider colleagues.

2022 was a dynamic year for cannabis industry policy with significant action on both the federal and state levels. Three leading U.S. cannabis policy and law experts, Kay Doyle, Kristine Blackwood, and Lauren Niehaus, joined CannabizMD Founder/CEO Jacquie Cohen Roth on a webinar sharing their insights lessons on 2022 and how the cannabis industry will move forward in 2023.  Collectively, the cannabis industry is operating in a unique regulatory framework with being federally illegal with U.S. states and territories leading the way as laboratories for creating sound policies and regulations.

President Joe Biden released the White House approach to federal marijuana (cannabis) reform in October 2022 and the first stand-alone cannabis bill became law in December 2022. New state medical cannabis programs came online and adult use was legalized in two states via ballot initiatives while three states’ legalization initiatives failed. The webinar discussion delivers tremendous insights on:

• what’s best for the cannabis industry in terms of rescheduling or descheduling
• the respective effect of both on the existing cannabis industry
• the best DEA schedule for cannabis
• the impact of the Marijuana and Cannabidiol Research Expansion Act
• the cannabis industry champions for the 118th Congressional session  
• Congressional action on cannabis on SAFE banking
• protections for patients in adult use markets
• strategies for advocacy

Tune in the webinar recording via the link below.